Bifidobacterium longum subsp. longum XZ01 delays the progression of colon cancer in mice through the interaction between the microbial spatial distribution and tumour immunity
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114283 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Ying Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; School of Pharmaceutical Sciences, Guangdong Yu…. Hauptthemen laut MEDLINE: Colonic Neoplasms, Probiotics, Bifidobacterium longum. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangzhou Municipal Science and Technology Program key projects, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Studies have shown that the colonisation of active microorganisms is more conducive to the development of tumour immunotherapy, but intuitive evidence regarding shaping of the tumour immune microenvironment is lacking. In this study, we used Bifidobacterium longum subsp. longum (XZ01) to intervene in a colon cancer mouse model and found that its mechanism may be related to the interaction between the spatial distribution of microorganisms and tumour immunity. Through the visualisation method we established, for the first time, we showed that harmful active bacteria such as Streptococcus and Rhodococcus specifically accumulate in the middle and upper layers of tumour tissue. These bacteria likely participate in signalling pathways that affect macrophages by directly contacting or invading the macrophages, leading to a nondifferentiated state in macrophages and the loss of some immune functions. Furthermore, the accumulation of Streptococcus and Rhodococcus fragments in the deep layer of tumour tissue likely upregulates the expression of IL-10 in tumour tissue and inhibits other immune cells, such as CD8+ T cells, DC and NK cells. In contrast, XZ01 can specifically compete for the growth sites of Streptococcus and Rhodococcus in the middle and upper layers of tumour tissue and probably protects macrophages from being invaded by harmful bacteria. XZ01 directly regulates the polarisation of M0 macrophages towards the M1 phenotype by upregulating IFN-γ, thus activating tumour immunity to inhibit the growth of tumour cells. This study revealed that the influence of active microorganisms on the tumour immune microenvironment is crucial for effective immunotherapy intervention, potentially offering new targets for improving patient prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; School of Pharmaceutical Sciences, Guangdong Yunfu Vocational College of Chinese Medicine, Yunfu 527300, China.
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
- School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518000, China.
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510006, China. Electron…
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China. Electronic address: zyfxliao@gzucm.edu.cn.
Förderung
- National Natural Science Foundation of China
- Guangzhou Municipal Science and Technology Program key projects
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Chen, Y., Wu, J., Cai, K., Xiao, X., Chen, Y., Zhang, X., Deng, S., Pei, C., Chen, Y., Xie, Z., Li, P., & Liao, Q. (2025). Bifidobacterium longum subsp. longum XZ01 delays the progression of colon cancer in mice through the interaction between the microbial spatial distribution and tumour immunity. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114283
Vancouver
Chen Y, Wu J, Cai K, Xiao X, Chen Y, Zhang X, et al. Bifidobacterium longum subsp. longum XZ01 delays the progression of colon cancer in mice through the interaction between the microbial spatial distribution and tumour immunity. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114283
BibTeX
@article{Chen2025,
author = {Chen, Ying and Wu, Jinyun and Cai, Kaiwei and Xiao, Xiaoyi and Chen, Ye and Zhang, Xingyuan and Deng, Song and Pei, Chaoying and Chen, Yanlong and Xie, Zhiyong and Li, Pei and Liao, Qiongfeng},
title = {Bifidobacterium longum subsp. longum XZ01 delays the progression of colon cancer in mice through the interaction between the microbial spatial distribution and tumour immunity},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114283}
}
EUVIMED